Detalhe da pesquisa
1.
Selective targeting of metastatic ovarian cancer using an engineered anthrax prodrug activated by membrane-anchored serine proteases.
Proc Natl Acad Sci U S A
; 119(28): e2201423119, 2022 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35867758
2.
Tubulin Complexity in Cancer and Metastasis.
Adv Exp Med Biol
; 1452: 21-35, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38805123
3.
Microtubule-Targeting Agents: Disruption of the Cellular Cytoskeleton as a Backbone of Ovarian Cancer Therapy.
Adv Exp Med Biol
; 1452: 1-19, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38805122
4.
In vitro fertilization: a cross-sectional analysis of 58 US insurance companies.
J Assist Reprod Genet
; 40(3): 581-587, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36542313
5.
A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability.
Cancer
; 128(6): 1206-1218, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34875107
6.
Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.
Br J Cancer
; 126(12): 1695-1703, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35149854
7.
Synergistic activity of neratinib in combination with olaparib in uterine serous carcinoma overexpressing HER2/neu.
Gynecol Oncol
; 166(2): 351-357, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35641325
8.
Malignant Sex Cord-Stromal Tumor, Not Otherwise Specified, Harboring FOXL2, p53, and TERT Promoter Mutations: Report of a Case.
Int J Gynecol Pathol
; 39(6): 567-572, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31789679
9.
Correction: Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.
Br J Cancer
; 130(6): 1073, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38438590
10.
Review of Immune Therapies Targeting Ovarian Cancer.
Curr Treat Options Oncol
; 19(12): 74, 2018 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30430276
11.
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma.
Proc Natl Acad Sci U S A
; 110(8): 2916-21, 2013 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-23359684
12.
Solitomab, an epithelial cell adhesion molecule/CD3 bispecific antibody (BiTE), is highly active against primary chemotherapy-resistant ovarian cancer cell lines in vitro and fresh tumor cells ex vivo.
Cancer
; 121(3): 403-12, 2015 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25251053
13.
Weekly ixabepilone with or without biweekly bevacizumab in the treatment of recurrent or persistent uterine and ovarian/primary peritoneal/fallopian tube cancers: A retrospective review.
Gynecol Oncol
; 137(3): 392-400, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25792179
14.
Use of Monsel solution to treat obstetrical hemorrhage: a review and comparison to other topical hemostatic agents.
Am J Obstet Gynecol
; 212(6): 725-35, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25577672
15.
A series of malignant ovarian cancers arising from within a mature cystic teratoma: a single institution experience.
Int J Gynecol Cancer
; 25(5): 792-7, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25790042
16.
Neratinib shows efficacy in the treatment of HER2/neu amplified uterine serous carcinoma in vitro and in vivo.
Gynecol Oncol
; 135(1): 142-8, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25124161
17.
Taxanes: their impact on gynecologic malignancy.
Anticancer Drugs
; 25(5): 522-35, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24300913
18.
Co-Packaged PARP inhibitor and photosensitizer for targeted photo-chemotherapy of 3D ovarian cancer spheroids.
Cell Biosci
; 14(1): 20, 2024 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38321470
19.
Early Implementation of Robotic Training in Surgical and Surgical Subspecialty Residency.
Am Surg
; 90(6): 1317-1323, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38262961
20.
Tubulin-ß-III overexpression by uterine serous carcinomas is a marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to epothilones.
Cancer
; 119(14): 2582-92, 2013 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23585021